ATE384783T1 - Dimerisierter wachstumsfaktor sowie materialien und verfahren zu seiner herstellung - Google Patents
Dimerisierter wachstumsfaktor sowie materialien und verfahren zu seiner herstellungInfo
- Publication number
- ATE384783T1 ATE384783T1 AT02773824T AT02773824T ATE384783T1 AT E384783 T1 ATE384783 T1 AT E384783T1 AT 02773824 T AT02773824 T AT 02773824T AT 02773824 T AT02773824 T AT 02773824T AT E384783 T1 ATE384783 T1 AT E384783T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- polypeptide chains
- amino acid
- polypeptide
- materials
- Prior art date
Links
- 239000000463 material Substances 0.000 title abstract 2
- 239000003102 growth factor Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 7
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 7
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 7
- 102000004169 proteins and genes Human genes 0.000 abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 108060003951 Immunoglobulin Proteins 0.000 abstract 1
- 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 abstract 1
- 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 abstract 1
- 108091008606 PDGF receptors Proteins 0.000 abstract 1
- 102000011653 Platelet-Derived Growth Factor Receptors Human genes 0.000 abstract 1
- 102100040682 Platelet-derived growth factor D Human genes 0.000 abstract 1
- 101710170209 Platelet-derived growth factor D Proteins 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 102000018358 immunoglobulin Human genes 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/49—Platelet-derived growth factor [PDGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Glass Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34611701P | 2001-10-19 | 2001-10-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE384783T1 true ATE384783T1 (de) | 2008-02-15 |
Family
ID=23358033
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02773824T ATE384783T1 (de) | 2001-10-19 | 2002-10-18 | Dimerisierter wachstumsfaktor sowie materialien und verfahren zu seiner herstellung |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7122351B2 (de) |
| EP (1) | EP1446478B1 (de) |
| JP (1) | JP2005506073A (de) |
| AT (1) | ATE384783T1 (de) |
| AU (1) | AU2002337920A1 (de) |
| CA (1) | CA2463003A1 (de) |
| DE (1) | DE60224822T2 (de) |
| DK (1) | DK1446478T3 (de) |
| ES (1) | ES2302845T3 (de) |
| WO (1) | WO2003033677A2 (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6287850B1 (en) * | 1995-06-07 | 2001-09-11 | Affymetrix, Inc. | Bioarray chip reaction apparatus and its manufacture |
| ES2629683T3 (es) | 1999-11-30 | 2017-08-14 | Mayo Foundation For Medical Education And Research | B7-H1, una nueva molécula inmunorreguladora |
| US7030219B2 (en) * | 2000-04-28 | 2006-04-18 | Johns Hopkins University | B7-DC, Dendritic cell co-stimulatory molecules |
| WO2003068802A2 (en) * | 2002-02-11 | 2003-08-21 | Zymogenetics, Inc. | Materials and methods for preparing dimeric growth factors |
| US7432351B1 (en) | 2002-10-04 | 2008-10-07 | Mayo Foundation For Medical Education And Research | B7-H1 variants |
| AR046594A1 (es) * | 2003-10-16 | 2005-12-14 | Applied Research Systems | Usos terapeuticos de variantes de quemoquina |
| ATE517914T1 (de) | 2004-03-08 | 2011-08-15 | Zymogenetics Inc | Dimere fusionsproteine und materialien und verfahren zu deren herstellung |
| SI3428191T1 (sl) | 2004-10-06 | 2025-03-31 | Mayo Foundation For Medical Education And Research | B7-H1 in PD-1 v zdravljenju karcinoma ledvičnih celic |
| US7473678B2 (en) | 2004-10-14 | 2009-01-06 | Biomimetic Therapeutics, Inc. | Platelet-derived growth factor compositions and methods of use thereof |
| US7799754B2 (en) * | 2004-10-14 | 2010-09-21 | Biomimetic Therapeutics, Inc. | Compositions and methods for treating bone |
| CA2630077C (en) | 2005-11-17 | 2014-07-15 | Biomimetic Therapeutics, Inc. | Maxillofacial bone augmentation using rhpdgf-bb and a biocompatible matrix |
| EP1801121A1 (de) * | 2005-12-23 | 2007-06-27 | CONARIS research institute AG | Lösliche Varianten des Moleküls gp130 nützlich als Arzneimittel |
| US9161967B2 (en) * | 2006-06-30 | 2015-10-20 | Biomimetic Therapeutics, Llc | Compositions and methods for treating the vertebral column |
| CA2656278C (en) * | 2006-06-30 | 2016-02-09 | Biomimetic Therapeutics, Inc. | Compositions and methods for treating rotator cuff injuries |
| AU2007333425B2 (en) | 2006-11-03 | 2014-03-27 | Stryker Corporation | Compositions and methods for arthrodetic procedures |
| EP2514762B1 (de) | 2007-07-13 | 2015-04-08 | The Johns Hopkins University | B7-DC-Varianten |
| WO2009093240A2 (en) * | 2008-01-24 | 2009-07-30 | Ademex Ltd. | Erythropoietin and fibronectin compositions for bone regeneration |
| CN102014977B (zh) | 2008-02-07 | 2015-09-02 | 生物模拟治疗有限责任公司 | 用于牵引成骨术的组合物和方法 |
| PL2350129T3 (pl) | 2008-08-25 | 2015-12-31 | Amplimmune Inc | Kompozycje antagonistów PD-1 i sposoby stosowania |
| BR122020000059B8 (pt) | 2008-09-09 | 2021-06-22 | Biomimetic Therapeutics Inc | composição que compreende uma matriz biocompatível e um fator de crescimento derivado de plaqueta e kit |
| CA2754501A1 (en) * | 2009-03-05 | 2010-09-10 | Biomimetic Therapeutics, Inc. | Platelet-derived growth factor compositions and methods for the treatment of osteochondral defects |
| CA2790403C (en) | 2010-02-22 | 2019-08-27 | Biomimetic Therapeutics, Inc. | Platelet-derived growth factor compositions and methods for the treatment of tendinopathies |
| US9133486B2 (en) * | 2012-03-12 | 2015-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Hydrogenase fusion protein for improved hydrogen production |
| AU2013240279A1 (en) * | 2012-03-30 | 2014-10-16 | Bayer Healthcare Llc | Protease-regulated antibodies |
| US9302005B2 (en) | 2013-03-14 | 2016-04-05 | Mayo Foundation For Medical Education And Research | Methods and materials for treating cancer |
| EP3052131B1 (de) | 2013-10-01 | 2018-12-05 | Mayo Foundation for Medical Education and Research | Verfahren zur krebsbehandlung bei patienten mit erhöhtem bim-spiegel |
| US10302653B2 (en) | 2014-05-22 | 2019-05-28 | Mayo Foundation For Medical Education And Research | Distinguishing antagonistic and agonistic anti B7-H1 antibodies |
| WO2016014148A1 (en) | 2014-07-23 | 2016-01-28 | Mayo Foundation For Medical Education And Research | Targeting dna-pkcs and b7-h1 to treat cancer |
| US10875923B2 (en) | 2015-10-30 | 2020-12-29 | Mayo Foundation For Medical Education And Research | Antibodies to B7-H1 |
| US12257286B2 (en) | 2018-10-31 | 2025-03-25 | Mayo Foundation For Medical Education And Research | Methods and materials for treating cancer |
| WO2020092839A1 (en) | 2018-10-31 | 2020-05-07 | Mayo Foundation For Medical Education And Research | Methods and materials for treating cancer |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5013653A (en) * | 1987-03-20 | 1991-05-07 | Creative Biomolecules, Inc. | Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage |
| US5336603A (en) * | 1987-10-02 | 1994-08-09 | Genentech, Inc. | CD4 adheson variants |
| US6018026A (en) * | 1988-01-22 | 2000-01-25 | Zymogenetics, Inc. | Biologically active dimerized and multimerized polypeptide fusions |
| DE721983T1 (de) * | 1988-01-22 | 2002-07-04 | Zymogenetics, Inc. | Verfahren zur herstellung von biologisch-aktive Dimerpeptiden |
| EP0452364B1 (de) | 1988-12-22 | 2002-05-22 | Genentech, Inc. | Verfahren zur herstellung von wasserlöslichen polypeptiden |
| US5116964A (en) * | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
| WO1995021258A1 (en) * | 1994-02-01 | 1995-08-10 | United States Of America, Represented By The Secretary, Department Of Health And Human Services | Fusion proteins that include antibody and nonantibody portions |
| US5731168A (en) * | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US20020137890A1 (en) * | 1997-03-31 | 2002-09-26 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| GB9720054D0 (en) * | 1997-09-19 | 1997-11-19 | Celltech Therapeutics Ltd | Biological products |
| ATE451389T1 (de) * | 1998-11-10 | 2009-12-15 | Ludwig Inst Cancer Res | Von blutplättchen abstammender wachstumsfaktor d, dafür kodierende dns und deren verwendungen |
| US6468543B1 (en) * | 1999-05-03 | 2002-10-22 | Zymogenetics, Inc. | Methods for promoting growth of bone using ZVEGF4 |
| CA2494705A1 (en) | 1999-12-01 | 2001-06-07 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| CA2398227A1 (en) | 2000-01-31 | 2001-08-02 | Human Genome Sciences, Inc. | 17 human secreted proteins |
| EP1294904A1 (de) | 2000-06-30 | 2003-03-26 | Vlaams Interuniversitair Instituut voor Biotechnologie vzw. | Heterodimäre fusionsproteine |
| IL157726A0 (en) | 2001-03-09 | 2004-03-28 | Zymogenetics Inc | Soluble heterodimeric cytokine receptor |
-
2002
- 2002-10-18 AT AT02773824T patent/ATE384783T1/de not_active IP Right Cessation
- 2002-10-18 US US10/274,638 patent/US7122351B2/en not_active Expired - Fee Related
- 2002-10-18 ES ES02773824T patent/ES2302845T3/es not_active Expired - Lifetime
- 2002-10-18 WO PCT/US2002/033563 patent/WO2003033677A2/en not_active Ceased
- 2002-10-18 DE DE60224822T patent/DE60224822T2/de not_active Expired - Fee Related
- 2002-10-18 DK DK02773824T patent/DK1446478T3/da active
- 2002-10-18 AU AU2002337920A patent/AU2002337920A1/en not_active Abandoned
- 2002-10-18 CA CA002463003A patent/CA2463003A1/en not_active Abandoned
- 2002-10-18 EP EP02773824A patent/EP1446478B1/de not_active Expired - Lifetime
- 2002-10-18 JP JP2003536407A patent/JP2005506073A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2463003A1 (en) | 2003-04-24 |
| WO2003033677A2 (en) | 2003-04-24 |
| US20030109000A1 (en) | 2003-06-12 |
| EP1446478B1 (de) | 2008-01-23 |
| WO2003033677A3 (en) | 2003-07-10 |
| DK1446478T3 (da) | 2008-06-02 |
| AU2002337920A1 (en) | 2003-04-28 |
| JP2005506073A (ja) | 2005-03-03 |
| ES2302845T3 (es) | 2008-08-01 |
| EP1446478A4 (de) | 2005-03-16 |
| US7122351B2 (en) | 2006-10-17 |
| DE60224822D1 (de) | 2008-03-13 |
| EP1446478A2 (de) | 2004-08-18 |
| DE60224822T2 (de) | 2009-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE384783T1 (de) | Dimerisierter wachstumsfaktor sowie materialien und verfahren zu seiner herstellung | |
| FI2784084T4 (fi) | Antagonistivasta-aineet IL-17A/F heterologisille polypeptideille | |
| Isaacs | Cystine knots | |
| Kurucz et al. | Correct disulfide pairing and efficient refolding of detergent-solubilized single-chain Fv proteins from bacterial inclusion bodies | |
| Mann et al. | Characterization of proteolytic fragments of the laminin‐nidogen complex and their activity in ligand‐binding assays | |
| DE69412614D1 (de) | Recombinante disulfid-stabilisierte polypeptide mit bindung spezifität | |
| JP3659261B2 (ja) | 組換体タンパク質の多機能性複合体への標的化ヘテロ結合 | |
| DE60043626D1 (de) | Verfahren zur therapeutischen Verwendung von löslichen rezeptoren BR43X2 | |
| SI2573121T1 (en) | Antibodies that bind IL-4 and/or IL-13 and their uses | |
| CA2318482A1 (en) | Il-18 receptors | |
| EA200501756A1 (ru) | Химерные гибриды мономер-димер иммуноглобулина | |
| JP2007500744A5 (de) | ||
| HRP20150444T1 (hr) | Trovalentna, bispecifiäśna protutijela | |
| CA2380569A1 (en) | Chimeric polypeptides, method for production and uses thereof | |
| CA2468583A1 (en) | Self-assembling multimeric binding complexes derived from ab5 toxin family members | |
| JP2002500886A5 (de) | ||
| IS8339A (is) | Mótlyf viðtaka NOGO | |
| WO2000023565B1 (en) | Novel neuropilin/growth factor binding and uses thereof | |
| WO2001083693A3 (en) | Compounds having affinity for the vascular endothelial growth factor receptor-2 (vegfr-2) and associated uses | |
| WO2003068802A3 (en) | Materials and methods for preparing dimeric growth factors | |
| BRPI0411766A (pt) | métodos para formar uma ligação de dissulfeto e para modificar quimicamente uma proteìna, um peptìdeo ou um aminoácido, composto, método para preparar o composto, uso do composto, e, proteìna, peptìdeo ou aminoácido | |
| FR2736916B1 (fr) | Proteines hetero-multimeriques recombinantes du type alpha-beta c4bp | |
| WO2007115150A3 (en) | Binding partners with immunoglobulin domains modified to have extended half-life | |
| McCartney et al. | Biosynthetic antibody binding sites: development of a single-chain Fv model based on antidinitrophenol IgA myeloma MOPC 315 | |
| WO2003014160A3 (en) | Cd44 variants carrying heparan sulfate chains and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1446478 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |